Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.

VY, Reddy; D, Holmes; SK, Doshi; P, Neuzil; S, Kar

doi:10.1161/circulationaha.110.976449

Public

Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.

Shared by NobleBlocks on Jan 17, 2011 • 12:00 AM UTC

Authors:

Reddy VY

Holmes D

Doshi SK

Abstract

Background The Watchman Left Atrial Appendage System for Embolic Protection in Patients With AF (PROTECT AF) randomized trial compared left atrial appendage closure against warfarin in atrial fibrillation (AF) patients with CHADS₂ ≥1. Although the study met the primary efficacy end point of being no...

Discussions